Results 31 to 40 of about 1,140,114 (148)

General treatment and wound management in hereditary epidermolysis bullosa: indication and experience using silver hydrofiber dressing [PDF]

open access: yesRevista Brasileira de Cirurgia Plástica, 2016
INTRODUCTION: Hereditary epidermolysis bullosa (EB) is a rare disorder characterized by cutaneomucous fragility, with formation of blisters during minimal trauma.
Fernanda Bianco Corrêa   +2 more
doaj   +1 more source

Carbonic anhydrase 2-derived drug-responsive domain regulates membrane-bound cytokine expression and function in engineered T cells

open access: yesCommunications Biology
Adoptive cell therapies (ACT) have shown reduced efficacy against solid tumor malignancies compared to hematologic malignancies, partly due to the immunosuppressive nature of the tumor microenvironment (TME). ACT efficacy may be enhanced with pleiotropic
Mara C. Inniss   +17 more
doaj   +1 more source

Gut microbiota: emerging biomarkers and potential therapeutics for premature ovarian failure

open access: yesFrontiers in Microbiology
Premature ovarian failure is a prevalent gynecological endocrine disorder with an increasing incidence rate each year, impacting women’s physical and mental health.
Zongyu Liu   +10 more
doaj   +1 more source

Therapeutics Letter 35

open access: yes, 2000
Therapeutics Letter 35 discusses sources of drug therapy information for clinicians, including online, subscription, and textbook sources. Bulletins, particularly The Medical Letter, the Drug and Therapeutics Bulletin from the UK and Prescrire ...
Therapeutics Initiative (University of British Columbia)
core   +1 more source

Structure of anellovirus-like particles reveal a mechanism for immune evasion

open access: yesNature Communications
Anelloviruses are nonpathogenic viruses that comprise a major portion of the human virome. Despite being ubiquitous in the human population, anelloviruses (ANVs) remain poorly understood.
Shu-hao Liou   +17 more
doaj   +1 more source

Lichenoid dysplasia treated by apremilast - report of two cases and review of literature

open access: yesJournal of Family Medicine and Primary Care
Lichenoid dysplasia (LD) is a distinct clinicopathologic condition characterized by bilateral or unilateral oral lesions with a lichenoid pattern and atypical cells, giving it a higher risk for malignant transformation. Unlike oral lichen planus (OLP) or
Shiladitya Sil   +3 more
doaj   +1 more source

Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets

open access: yesMedical Review
Alzheimer’s disease (AD) is a chronic neurodegenerative disorder for which there are currently no effective treatment options. Increasing evidence suggests that AD is a systemic disease closely associated with the immune system, not merely a central ...
Fu Xiaofeng   +5 more
doaj   +1 more source

Therapeutics Letter 86

open access: yes, 2012
Therapeutics Letter 86 provides results of the Therapeutics Initiative's (TI) fourth readership survey to evaluate perceptions of TI educational activities.Medicine, Faculty ofAnesthesiology, Pharmacology and Therapeutics, Department ofReviewedThe UBC TI
Therapeutics Initiative (University of British Columbia)
core   +1 more source

Modulation of Biological Membranes Using Small-Molecule Compounds to Counter Toxicity Caused by Amyloidogenic Proteins

open access: yesMembranes
The transition of peptides or proteins along a misfolding continuum from soluble functional states to pathological aggregates, to ultimately deposit as amyloid fibrils, is a process that underlies an expanding group of human diseases—collectively known ...
Raina Marie Seychell   +2 more
doaj   +1 more source

Therapeutics Letter 16

open access: yes, 1996
Therapeutics Letter 16 reviews thirteen recent clinical trials that pertain to nine previous Therapeutics Letters. Topics covered include H. pylori and gastroesophageal reflux, treatment of angina and hypertension, risks and benefits of calcium channel ...
Therapeutics Initiative (University of British Columbia)
core   +1 more source

Home - About - Disclaimer - Privacy